- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
51 Primary Progressive Aphasia Trials Near You
Power is an online platform that helps thousands of Primary Progressive Aphasia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerGene Therapy for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
9 Participants Needed
AL001 for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
110 Participants Needed
Trappsol Cyclo for Niemann-Pick Disease
Trial Details
Key Eligibility Criteria
94 Participants Needed
Speech Sequencing Therapies for Stuttering
Trial Details
Key Eligibility Criteria
2 Participants Needed
Nabilone for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
45 Participants Needed
AL001 for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
40 Participants Needed
Oxytocin Nasal Spray for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
112 Participants Needed
(18F)-FEPPA PET/MRI Imaging for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
40 Participants Needed
Speech-Language Therapy for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
200 Participants Needed
Communication Bridge for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
12 Participants Needed
Tau PET Imaging for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
70 Participants Needed
Verdiperstat for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
64 Participants Needed
Gene Therapy for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
25 Participants Needed
Deep Brain Stimulation for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
6 Participants Needed
tDCS + Language Therapy for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
180 Participants Needed
tDCS + Speech-Language Therapy for Aphasia
Trial Details
Key Eligibility Criteria
60 Participants Needed
HD-tDCS + Language Therapy for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
60 Participants Needed
tDCS + Cognitive Training for Dementia
Trial Details
Key Eligibility Criteria
50 Participants Needed
Trial Details
Key Eligibility Criteria
90 Participants Needed
Vortioxetine for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
50 Participants Needed
Why Other Patients Applied
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Retinal Imaging for Neurodegenerative Disease
Trial Details
Key Eligibility Criteria
2000 Participants Needed
IV VTS-270 for Niemann-Pick Disease
Trial Details
Key Eligibility Criteria
12 Participants Needed
HD-tDCS + mCILT for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
66 Participants Needed
PR006 for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
30 Participants Needed
DNL593 for Frontotemporal Dementia
Trial Details
Key Eligibility Criteria
106 Participants Needed
Behavioral Nudge for Genetic Predisposition
Trial Details
Key Eligibility Criteria
1000 Participants Needed
WeCareAdvisor for Caregiver Support in Dementia
Trial Details
Key Eligibility Criteria
262 Participants Needed
N-Acetyl-L-Leucine for Niemann-Pick Disease Type C
Trial Details
Key Eligibility Criteria
53 Participants Needed
Brain Inflammation Imaging for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
100 Participants Needed
Propranolol for Primary Progressive Aphasia
Trial Details
Key Eligibility Criteria
30 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Primary Progressive Aphasia clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Primary Progressive Aphasia clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Primary Progressive Aphasia trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Primary Progressive Aphasia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Primary Progressive Aphasia medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Primary Progressive Aphasia clinical trials?
Most recently, we added STELLA-FTD for Frontotemporal Dementia, Vortioxetine for Frontotemporal Dementia and Propranolol for Primary Progressive Aphasia to the Power online platform.